Assessment of cardiovascular risk in type 1 diabetes mellitus taking into account various markers of kidney damage
- Autores: Goldschmid A.E1, Karamullina R.A1, Chechikova E.I1, Amosova M.V1, Poluboyarinova I.V1, Fadeev V.V1
-
Afiliações:
- Sechenov First Moscow State Medical University (Sechenov University)
- Edição: Volume 12, Nº 4 (2020)
- Páginas: 51-55
- Seção: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273320
- DOI: https://doi.org/10.18565/nephrology.2020.4.51-55
- ID: 273320
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
A. Goldschmid
Sechenov First Moscow State Medical University (Sechenov University)
Email: goldsmid93@gmail.com
Endocrinologist Moscow, Russia
R. Karamullina
Sechenov First Moscow State Medical University (Sechenov University)Postgraduate student Moscow, Russia
E. Chechikova
Sechenov First Moscow State Medical University (Sechenov University)Medical Resident Moscow, Russia
M. Amosova
Sechenov First Moscow State Medical University (Sechenov University)Cand. Sci. (Med.), Teaching Assistant at the Department of Endocrinology №1 Moscow, Russia
I. Poluboyarinova
Sechenov First Moscow State Medical University (Sechenov University)Cand. Sci. (Med.), Teaching Assistant at the Department of Endocrinology №1 Moscow, Russia
V. Fadeev
Sechenov First Moscow State Medical University (Sechenov University)Corresponding member of RAS, Dr. Sci. (Med.), Professor, Director of the Clinic, Head of the Department of Endocrinology № 1 Moscow, Russia
Bibliografia
- Sharma H., Lencioni M., Narendran P. Cardiovascular disease in type 1 diabetes. Cardiovasc. Endocrinol. Metab. 2019;8(1):28-34. Doi:10.1097/ XCE.0000000000000167.
- Dedov I.I., Shestakova M.V., Vikulova O.K. Epidemiology of diabetes mellitus in Russian Federation: Clinical and statistical report according to the federal diabetes registry. Diab. Mellit. 2017;20(1):13-41. doi: 10.14341/DM8664.
- Morimoto A., Onda Y., Nishimura R., et al. Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study. Diabetol. 2013;56(10):2171-5. doi: 10.1007/s00125-013-3001-2.
- Libby P., Nathan D.M., Abraham K., et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111(25):3489-93. Doi: 10.1161/ CIRCULATIONAHA.104.529651.
- UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetol. 1991;34(12):877-90.
- Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., Colhoun H.M. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diab. Care. 2006;29(4):798-804. Doi: 10.2337/ diacare.29.04.06.dc05-1433.
- Mattock M.B., Morrish N.J., Viberti G., Keen H., Fitzgerald A.P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41(6):736-41. Doi: 10.2337/ diab.41.6.736.
- Wu T., McGrath K.C.Y, Death A.K. Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers? Vasc. Health. Risk Manag. 2005;1(4):309-16. doi: 10.2147/vhrm.2005.1.4.309.
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. (London, England). 1998;352(9131):837-53.
- de Zeeuw D., Remuzzi G., Parving H-H., et al. Albuminuria, a therapeutic targetfor cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921-7. doi: 10.1161/01.CIR.0000139860.33974.28.
- Anavekar N.S., Gans D.J., Berl T., et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int. 2004;92( Suppl.):S50-5. Doi: 10.1111/j. 1523-1755.2004.09213.x.
- Cederholm J., Eeg-Olofsson K., Eliasson B., Zethelius B., Gudbjornsdottir S. A new modelfor 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR). Diab. Med. 2011;28(10):1213- 20. doi: 10.1111/j.1464-5491.2011.03342.x.